Tailoring the need for combination immunosuppressive therapy in IBD patients initiating anti-TNF agents using pre-biologic HLA-DQA1*05 screening: a prospective study

被引：1
|
作者：
Gonzalez, Haidee Aleman [1 ]
Whitehead, Emma [1 ]
Pattinson, Alison [1 ]
Stamp, Katie [1 ]
Turnbull, Jack [1 ]
Robertson, Hayley [1 ]
Nautista, Nanete [1 ]
Talbot, Alison [1 ]
Aranda, Lola [1 ]
Sebastian, Shaji [1 ]
机构：
[1] Hull Univ Teaching Hosp, IBD Unit, Kingston Upon Hull, N Humberside, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.162
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P90
引用
收藏
页码：A100 / A101
页数：2
相关论文
共 17 条
  • [1] Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
    Gonzalez, H. Aleman
    Ramachandran, S.
    Whitehead, E.
    Pattinson, A.
    Stamp, K.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I342 - I342
  • [2] INCORPORATING HLADQA1*05 IN PRE-BIOLOGIC SCREENING IN IBD PATIENTS INITIATING BIOLOGIC THERAPIES
    Gonzalez, Haidee Aleman
    Ramachandran, Sankaranarayanan
    Whitehead, Emma
    Pattinson, Alison
    Stamp, Katie
    Turnbull, Jack
    Myers, Sally
    Talbot, Alison
    Sebastian, Shaji
    GUT, 2021, 70 : A97 - A98
  • [3] Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
    Gonzalez, H. Aleman
    Ramachandran, S.
    Whitehead, E.
    Pattinson, A.
    Stamp, K.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I342 - I342
  • [4] HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS
    Bergstein, Suzannah
    Spencer, Elizabeth
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S58 - S58
  • [5] HLA-DQA1*05 ASSOCIATES WITH IMMUNOGENICITY AND LOSS OF RESPONSE TO ANTI-TNF THERAPY IN THE IBD POPULATION: A META-ANALYSIS
    Bergstein, Suzannah
    Spencer, Elizabeth
    GASTROENTEROLOGY, 2023, 164 (04) : S74 - S74
  • [6] HLA-DQA1*05 associates with immunogenicity and loss of response to anti-TNF therapy in the IBD population: A meta-analysis
    Bergstein, S.
    Spencer, E. A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I148 - I149
  • [7] Withdrawal of immunomodulatory therapy is feasible in anti-TNF treated patients with negative HLA-DQA1*05-an observational study
    Gonzalez, Haidee Aleman
    Whitehead, Emma
    Pattinson, Alison
    Stamp, Katie
    Turnbul, Jack
    Bautista, Nannet
    Robertson, Hayley
    Sebastian, Shaji
    GUT, 2023, 72 (SUPPL_2) : A102 - A102
  • [8] HLA-DQA1*05 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE
    Doherty, Jayne
    Ryan, Anthony W.
    Quinn, Emma
    Dolan, Jackie
    Corcoran, Roisin
    O'Hara, Fintan
    Bailey, Yvonne
    Mcnamara, Deirdre
    Doherty, Glen
    Kevans, David
    GASTROENTEROLOGY, 2023, 164 (06) : S435 - S436
  • [9] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, Jayne
    Ryan, Anthony W.
    Quinn, Emma
    Conroy, Judith
    Dolan, Jackie
    Corcoran, Roisin
    Hara, Fintan O.
    Cullen, Garret
    Sheridan, Juliette
    Bailey, Yvonne
    Dunne, Cara
    Hartery, Karen
    Mcnamara, Deirdre
    Doherty, Glen A.
    Kevans, David
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [10] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, J.
    Ryan, A.
    Quinn, E.
    Dolan, J.
    Corcoran, R.
    Hara, F. O'
    Bailey, Y.
    McNamara, D.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 734 - 734
12